SCHEMBL6403337

SCHEMBL6403337

Cc1nnc(SCc2nc3ccccc3[nH]2)[nH]1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 9/20 0.62
RAB9A P51151 7/20 0.62
NPC1 O15118 6/20 0.62
ALDH1A1 P00352 5/20 0.62
HPGD P15428 3/20 0.62
ABL1 P00519 1/20 0.60
RIN1 Q13671 1/20 0.60
CYP1A2 P05177 1/20 0.60
CYP3A4 P08684 1/20 0.60
CYP2D6 P10635 1/20 0.60
CYP2C9 P11712 1/20 0.60
CYP2C19 P33261 1/20 0.60
LMNA P02545 6/20 0.55
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
POLB P06746 1/20 0.55
L3MBTL1 Q9Y468 2/20 0.53
THRB P10828 2/20 0.53
GAA P10253 2/20 0.53
HTT P42858 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6404864 0.78 SMN1; SMN2 (0.53) SMN1; SMN2RAB9ANPC1ALDH1A1HPGD
SCHEMBL9667165 0.75 RAB9A (0.68) SMN1; SMN2RAB9ANPC1ALDH1A1HPGD
SCHEMBL3429462 0.75 SMN1; SMN2 (1.00) SMN1; SMN2RAB9ANPC1ALDH1A1HPGD
SCHEMBL11130494 0.75 NPC1 (0.65) SMN1; SMN2RAB9ANPC1ALDH1A1HPGD
SCHEMBL3065316 0.74 SMN1; SMN2 (0.69) SMN1; SMN2RAB9ANPC1ALDH1A1HPGD
SCHEMBL3079520 0.74 SMN1; SMN2 (0.83) SMN1; SMN2RAB9ANPC1ALDH1A1HPGD
SCHEMBL6408107 0.73 ALDH1A1 (0.67) SMN1; SMN2RAB9ANPC1ALDH1A1LMNA
SCHEMBL6485274 0.73 NPC1 (0.73) SMN1; SMN2RAB9ANPC1ALDH1A1HPGD
SCHEMBL11887629 0.72 NPC1 (0.69) SMN1; SMN2RAB9ANPC1ALDH1A1HPGD
SCHEMBL9665950 0.72 RAB9A (0.63) SMN1; SMN2RAB9ANPC1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT SMN1; SMN2 4793/4885RAB9A 4278/4885NPC1 2070/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.